Alpine Partners VI »

Janux Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $425k 10k 41.89

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
Woodline Partners
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co

View all funds holding Janux Therapeutics